Onkologische Studien
Protokoll-Nr. | SAKK 35/15 |
Sponsor | SAKK - SWISS GROUP FOR CLINICAL CANCER RESEARCH, |
EudraCT-Nr. | 2017-001175-23 |
Studie der Inneren Medizin 3 |
Protokoll-Nr. | 20150288 |
Sponsor | Amgen Inc |
EudraCT-Nr. | 2016-002190-35 |
Studie der Inneren Medizin 3 |
Protokoll-Nr. | 20150290 |
Sponsor | Amgen Inc |
EudraCT-Nr. | 2016-002191-27 |
Studie der Inneren Medizin 3 |
Protokoll-Nr. | MK3475-412 |
Sponsor | Merck KGaA |
EudraCT-Nr. | 2016-003934-25 |
Studie der HNO |
Protokoll-Nr. | MK3475-365 |
Sponsor | Merck Sharp & Dohme Corp |
EudraCT-Nr. | 2016-002312-41 |
Studie der Urologie |
Protokoll-Nr. | ACE-LY-308 |
Sponsor | Acerta Pharma |
EudraCT-Nr. | 2015-005220-26 |
Studie der Inneren Medizin 3 |
Neurologische Studien
Protokoll-Nr | BP39529 (PASADENA) |
Sponsor | F. Hoffmann-La Roche Ltd |
EudraCT-Nr | 2017-000087-15 |
Protokoll-Nr | CLCZ696B2320 |
Sponsor | Novartis |
EudraCT-Nr | 2016-001254-17 |
Protokoll-Nr | 814907-CS1 |
Sponsor | IONIS |
EudraCT-Nr | 2016-002713-22 |
Protokoll-Nr | BN29552 |
Sponsor | F. Hoffmann-La Roche Ltd |
EudraCT-Nr | 2015-003034-27 |
Protokoll-Nr | 221AD302 |
Sponsor | Biogen MA Inc |
EudraCT-Nr | 2015‐000967‐15 |